All Mergers and acquisitions articles – Page 6
-
Business
Pharmaceutical industry roundup of 2016
Controversial approvals and price clashes characterised 2016 in pharma
-
Business
Pfizer pulls back on UK and Ireland facilities
€400 million manufacturing plant expansion cancelled and two facilities to close
-
Business
OCP to invest $3.7bn in Ethiopian fertiliser plant
Output from joint venture between Ethiopian government and Moroccan state phosphate group will exceed domestic demand
-
Business
EU scrutinises Syngenta–ChemChina union
European commission investigates competition concerns in agricultural megamerger
-
Business
AstraZeneca sheds multiple drugs
Spate of licensing deals for non-core products as firm further tightens R&D focus
-
Business
India’s Intas bags UK and Irish generics
Teva sheds former Actavis business to satisfy competition requirements of its Allergan generics takeover
-
Business
Pfizer to sell Hospira Infusion Systems to ICU Medical
$1bn deal brings together medical device units, as Pfizer focuses on Hospira’s biosimilars and generics
-
Business
Lilly to buy Boehringer’s pet vaccines
Deal strengthens Lilly’s animal medicine division following recent acquisition
-
Business
Lanxess to buy Chemtura for additives
€2.4 billion deal brings lubricant additives and flame retardants expertise and expands North American operations
-
Business
Pfizer scraps plans to split
Previously separated ‘innovative’ and ‘value’ business segments will remain autonomous under Pfizer umbrella
-
Business
US senators examine agrochem consolidation
Judiciary committee voices concern over pending merger deals
-
Business
Acquisition spree moves Allergan towards innovative drugs
Company acquires five companies in six weeks across three disease areas
-
Business
J&J to buy Abbott Medical Optics
Deal adds laser surgery and cataract lens replacements to J&J’s eyecare business
-
Business
Danaher boosts diagnostics with Cepheid buyout
$4bn deal strengthens Danaher’s life sciences portfolio
-
Business
Fertiliser firms Agrium and PotashCorp to merge
Canadian combination will create one of the largest crop nutrient companies in the world.
-
Business
Bayer to buy seed giant Monsanto
$66bn deal follows agrochemical consolidation trend, but could threaten competition and hit R&D
-
-
Business
Pfizer to buy Astrazeneca’s antibiotics
Deal tops up Pfizer’s late-stage development pipeline, but AZ will retain biological programmes
-
Business
Pfizer gambles on $14bn Medivation deal
Cancer specialist likely just one target in hunt for marketed drugs to offset patent expiries
-
Business
EU examines Dow–DuPont union
European commission probes competition implications of the planned mega-merger